Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

5.82
Delayed Data
As of Jul 31
 +0.06 / +1.04%
Today’s Change
5.71
Today|||52-Week Range
10.26
-24.51%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$965.7M

Company Description

PDL BioPharma, Inc. is a biotechnology company. Its manages a portfolio of patents and royalty assets, which consist of its Queen et al, antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. The company also focused on the intellectual property asset management, acquiring new income generating assets, and maximizing value for its shareholders. PDL BioPharma was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Contact Information

PDL BioPharma, Inc.
932 Southwood Boulevard
Incline Village Nevada 89451
P:(775) 832-8500
Investor Relations:

Employees

Shareholders

Mutual fund holders48.89%
Other institutional36.22%
Individual stakeholders2.66%

Top Executives

John Peter McLaughlinPresident, Chief Executive Officer & Director
Peter S. GarciaChief Financial Officer & Vice President
Christopher Lewis StoneSecretary, Vice President & General Counsel
Danny J. HartVice President-Business Development
Steffen PietzkeChief Accounting Officer & Controller